{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:49:23Z","timestamp":1764510563302},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.wneu.2016.12.122","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T20:02:12Z","timestamp":1483646532000},"page":"808.e1-808.e2","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Mantle Cell Lymphoma with Central Nervous System Involvement Simulating Bilateral Subdural Hematomas"],"prefix":"10.1016","volume":"99","author":[{"given":"Luis Germ\u00e1n","family":"Gonz\u00e1lez-Bonet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raimundo","family":"Garc\u00eda-Boyero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Gaona-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2016.12.122_bib1","series-title":"WHO Classification of Tumours of the Hematopoeitic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.wneu.2016.12.122_bib2","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/annonc\/mdt139","article-title":"Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network","volume":"24","author":"Cheah","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.wneu.2016.12.122_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.1996.14.3.941","article-title":"CNS involvement in mantle-cell lymphoma","volume":"14","author":"Montserrat","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.wneu.2016.12.122_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s002770050491","article-title":"Central nervous system involvement in patients with mantle cell lymphoma","volume":"78","author":"Oinonen","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1016\/j.wneu.2016.12.122_bib5","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2015-05-647834","article-title":"Activity of ibrutinib in mantle cell lymphoma patients with central nervous system relapse","volume":"126","author":"Bernard","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.wneu.2016.12.122_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.14122","article-title":"Ibrutinib is a safe and effective therapy for systemic mantle cell lymphoma with central nervous system involvement \u2013 a multi-centre case series from the United Kingdom [e-pub ahead of print]","author":"Tucker","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.wneu.2016.12.122_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma","volume":"369","author":"Wang","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2016.12.122_bib8","first-page":"34","article-title":"Intracranial malignant B-cell lymphoma of the dura","volume":"19","author":"Freudenstein","year":"2000","journal-title":"Clin Neuropathol"},{"key":"10.1016\/j.wneu.2016.12.122_bib9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.wneu.2016.05.084","article-title":"Subdural hematoma mimickers: a systematic review","volume":"93","author":"Catana","year":"2016","journal-title":"World Neurosurg"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875016314371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875016314371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T08:56:09Z","timestamp":1536137769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875016314371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":9,"alternative-id":["S1878875016314371"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2016.12.122","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mantle Cell Lymphoma with Central Nervous System Involvement Simulating Bilateral Subdural Hematomas","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2016.12.122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}